- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03720236
Peri-implant Tissues in BLX® Implants (BLX)
July 2, 2020 updated by: Mario Pérez Sayáns, University of Santiago de Compostela
Behavior of Peri-implant Tissues in BLX® Implants Placed on Mature Scarred Bone
This is a randomized triple-blind clinical trial to evaluate the behavior of peri-implant tissues (bone and soft tissues) in BLX implants loaded early or delayed and with different surgical milling protocols.
To this end, 40 BLX implants with a diameter of 3.75x10 will be placed in areas of mature bone scarred after extraction.
They will be divided into 2 study groups, and these in turn into two subgroups.
Group A: complete milling, Group B: partial milling.
Each group will be assigned with code 1: early load and code 2: deferred load.
Clinical and radiological parameters will be evaluated.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
A Coruña
-
Santiago De Compostela, A Coruña, Spain, 15785
- Mario Pérez Sayáns
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients without systemic pathology
- Adult of age who agree to be part of the study and sign the informed consent.
- Patients smoking less than 5 cigarettes / day,
- Patients not being completely edentulous
- Unitary / multiple absences in the area posterior with or without free ends to distal, maxillary or mandibular that do not require regenerative techniques
- Area of mature bone healed at least 6 months post-extraction.
- The minimum torque for early loading will be 25 N. The placement of the implant will be mechanical up to 40 N maximum and manually finished with a surgical dynamometer.
- The placement of the abutment will be at a minimum of 25 N, in case the primary stability of the implant allows it, it will be placed at 35 N.
- The placement of the implant must always be 4 mm below the future gingival margi
Exclusion Criteria:
- Immunosuppressed patients
- Aesthetic edentulous areas of 13-23 and 33-43
- Smokers of more than 5 cigarettes
- Implants with a lower torque whose will be submerged with a screw and a protocol will be followed in 2 phases, being discarded from the study.
- Index of bleeding greater than 30%
- Patients with less than 2 mm of keratinized gingiva
- Implants with ISQ index <55
- When a margin of 1 mm safety cannot be assumed to the inferior dental nerve
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Full preparation
Group A: the complete milling protocol indicated by the manufacturer for the 3.75x10 mm BLX implant will be performed.
|
This is the first surgical phase, we prepare the implant bed by using different increasing size drills.
Other Names:
|
Experimental: Partial preparation
Group B: the partial / under milling protocol for the 3.75x10 mm implant, indicated by the manufacturer, will be carried out.
|
This is the first surgical phase, we prepare the implant bed by using different increasing size drills.
Other Names:
|
Experimental: Deferred loading
Code 2: for implants with this random code, the prosthetic prosthesis SRA of 2.5 mm and its corresponding healing plug of 5.1 mm will be placed.
Impressions will be taken at 6 weeks to place the provisional prosthesis at 8 weeks.
At 6 months the final impressions will be taken for the definitive load.
|
This is the second phase, based on prosthetic procedures, to design the crown over the dental implant
Other Names:
|
Experimental: Immediate load
The code 1: to the implants with this random code, the prosthetic prosthesis SRA of 2.5 mm and its corresponding healing plug of 5.1 mm will be placed.
The impression will be made in the same surgery and the placement of the provisional prosthesis before 7 days.
At 6 months the final impressions will be taken for the definitive load.
|
This is the second phase, based on prosthetic procedures, to design the crown over the dental implant
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary stability of implants and peri-implant tissues
Time Frame: 12 months
|
Randomly and following the inclusion and exclusion criteria, the implants will be placed with the normal preparation protocol (n = 20) and with the preparation protocol with under-fresh (n = 20).
We will evaluate the immediate post-surgical stability of implants and peri-implant tissues through the Ostell system, based on the resonance frequency analysis (RFA).
The implant stability quotient (ISQ) is the value on a scale that indicates the level of stability and osseointegration in dental implants.
The scale ranges from 1 to 100, with higher values indicating greater stability.
The acceptable stability range lies between 55-85 ISQ
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Basal Peri-implant tissue level: implant stability
Time Frame: 1 day
|
Randomly and following the inclusion and exclusion criteria, the implants will be placed with the normal preparation protocol (n = 20) and with the preparation protocol with under-fresh (n = 20).
We will load the crowns in two different groups, code 1: loading the implants before 7 days after surgery; code 2: before 8 weeks after implant surgery.
We will evaluate the stability at different moments, 8 weeks, 6 months and 12 months.The implant stability quotient (ISQ) is the value on a scale that indicates the level of stability and osseointegration in dental implants.
The scale ranges from 1 to 100, with higher values indicating greater stability.
The acceptable stability range lies between 55-85 ISQ.
ISQ values are obtained using resonance frequency analysis (RFA).
|
1 day
|
Basal Radiological Bone Implant level
Time Frame: 1 day
|
At the moment of placing the implant a periapical radiography will be performed, considering this measure the basal radiological bone level (distance from the neck of the implant to the most crestal level of the alveolar bone).
We will calculate the difference between the basal measure and the future measurements.
|
1 day
|
Basal Peri-implant tissue level: probing depth
Time Frame: 1 day
|
At the moment of placing the implant, clinical variables will be evaluated: depth of probing (distance from the peri-implant margin to the most depth of the peri-implant sulcus).
This will be the basal measure of the implant stability and peri-implant tissue levels.
We will calculate the difference between the basal measure and the future measurements.
|
1 day
|
Radiological bone implant stability
Time Frame: 6 weeks
|
After the implantation, we´ll load the temporary prostheses in two different moments, 7 days or 8 weeks depending of the aleatory coding.
We will evaluate the bone level stability at 6 weeks in both groups.
The bone stability will be measured as a difference between de basal bone level and the actual one in mm.
|
6 weeks
|
Peri-implant tissue stability: probing depth
Time Frame: 6 weeks
|
After the implantation, we´ll load the temporary prostheses in two different moments, 7 days or 8 weeks depending of the aleatory coding.
We will evaluate the peri-implant tissue stability by measuring the probing depth or just in case, the recession of the gingival margin.
The stability will be gave by the differences between both measures, basal and actual in mm.
|
6 weeks
|
Peri-implant tissue stability: ISQ
Time Frame: 6 weeks
|
After the implantation, we´ll load the temporary prostheses in two different moments, 7 days or 8 weeks depending of the aleatory coding.
We will evaluate the peri-implant tissue stability by measuring the ISQ through RFA.
The stability will be gave by the differences between both measures, basal and actual.
|
6 weeks
|
Clinical tissue levels of definitive prostheses: probing depth
Time Frame: 6 months
|
The final or definitive prostheses will be inserted in all groups at 6 months.
At this time, we will measure the clinical probing depth, comparing with previous measurements.
|
6 months
|
Clinical tissue levels of definitive prostheses: ISQ
Time Frame: 6 months
|
The final or definitive prostheses will be inserted in all groups at 6 months.
At this time, we will measure the implant stability through RFA, comparing with previous measurements.
|
6 months
|
Radiological tissue levels of definitive prostheses: bone implant level
Time Frame: 6 months
|
The final or definitive prostheses will be inserted in all groups at 6 months.
At this time, we will measure the bone implant level by measuring the distance from de implant neck to the most apical inserted bone, comparing simultaneously with previous measurements.
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Long-term evaluation of definitive prostheses
Time Frame: 12 months
|
After 6 months of loading of final ceramic restoration, we will evaluate the differences of clinical (mm of probing depth, ISQ implant stability) and radiological aspects (bone implant level in mm calculated from the neck to the actual bone level, comparing on the basal, the intermediate, and final values.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Mario Perez Sayans, PhD, University of Santiago de Compostela
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 2, 2018
Primary Completion (Actual)
January 10, 2019
Study Completion (Actual)
June 19, 2020
Study Registration Dates
First Submitted
October 5, 2018
First Submitted That Met QC Criteria
October 23, 2018
First Posted (Actual)
October 25, 2018
Study Record Updates
Last Update Posted (Actual)
July 7, 2020
Last Update Submitted That Met QC Criteria
July 2, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CT-2018-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
We will anonymize and categorize the clinical and radiological data of the patients to share the information with the other researchers of the group (n=9)
IPD Sharing Time Frame
From the beginning to sex month after finishing the study
IPD Sharing Access Criteria
Under request
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Implant Failed
-
Istanbul Medipol University HospitalCompletedDental Implant Failed | Osseointegration Failure of Dental ImplantTurkey
-
Kafrelsheikh UniversityRecruitingDental Implant Failed | Implant ComplicationEgypt
-
Universitat Internacional de CatalunyaRecruitingDental Implant FailedSpain
-
Cairo UniversityCompletedDental Implant FailedEgypt
-
Universidade Católica PortuguesaDanilo FernandesCompleted
-
Universidade Católica PortuguesaCompletedDental Implant FailedPortugal
-
Universidad de MurciaNot yet recruitingDental Implant Failed
-
University of BaghdadCompleted
-
Aalborg University HospitalDentsply InternationalActive, not recruiting
-
Cairo UniversityBioHorizons, Inc.Completed
Clinical Trials on Implant bed preparation protocol
-
University of ValenciaJuan Carlos Bernabeu Mira; Miguel Peñarrocha DiagoCompleted
-
Cairo UniversityUnknown
-
International Piezosurgery AcademyCompleted
-
Krishnadevaraya College of Dental Sciences & HospitalCompletedBone Density | Implant StabilityIndia
-
International Piezosurgery AcademyUniversity of Trieste; University of FoggiaCompleted
-
Luigi CanulloRecruitingTooth Loss | Edentulous Alveolar Ridge | Missing TeethItaly
-
Azhar ALI ELSAYED SELEEMUnknownCrestal Bone Resorption | Implant Primary Stability | Implant Osseointegration
-
University of LiegeRecruitingDental Prosthesis Failure | Dental Implant FailureBelgium
-
University of CagliariNot yet recruiting
-
University of IowaNot yet recruiting